How Your Body Processes an Experimental Cancer Drug
Treatments studied
Part of Cancer clinical trials.
This study tests how a new experimental drug called AZD1390 moves through and is processed by your body. Researchers use a specially labeled version of the drug to track this process, which may help them understand how to use it safely in future cancer patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (like lung, breast, or colon cancer) that is advanced or has spread, but not lymphoma
- You are not currently receiving active cancer treatment
- Your overall health and energy level are good (able to do light activities), with no decline in the past 2 weeks
- You are expected to live at least 12 more weeks
- Your kidneys, liver, and blood counts are working well enough
- You have regular bowel movements and no severe recent weight loss from cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests AZD9574 alone or with other cancer treatments in people with advanced solid tumors. It focuses on cancers with specific DNA repair gene changes (like BRCA1/2) or other matching tumor features, and aims to see if the treatment can shrink tumors and improve outcomes.
This study tests a new experimental drug (AZD8359) designed to target prostate cancer cells in men whose cancer has progressed despite previous treatments. The drug works by directing immune cells to attack cancer cells.
This trial tests a new drug called AZD6750 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
This trial tests a new drug called AZD0901 for people with advanced solid tumors that have a specific protein on their surface. It aims to see if the drug can shrink or slow the growth of these tumors.
This trial is testing a new medicine, AZD9793, for people with advanced or metastatic solid tumors that have a specific marker called GPC3. The goal is to see if AZD9793 can help shrink or control the cancer.
This trial tests a new drug called AVZO-1418, either alone or with other treatments, for people with advanced solid tumors that have spread or cannot be removed. The goal is to see if the drug is safe and effective against certain types of cancer.
Hear when a new Advanced Solid Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.